Napodano, Cecilia
 Distribuzione geografica
Continente #
NA - Nord America 1.961
AS - Asia 1.398
EU - Europa 1.373
SA - Sud America 318
AF - Africa 37
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.100
Nazione #
US - Stati Uniti d'America 1.903
SG - Singapore 742
SE - Svezia 427
CN - Cina 318
BR - Brasile 273
IT - Italia 246
DE - Germania 171
FR - Francia 101
IE - Irlanda 99
GB - Regno Unito 91
IN - India 63
VN - Vietnam 59
ID - Indonesia 53
RU - Federazione Russa 48
FI - Finlandia 44
CA - Canada 26
JP - Giappone 25
MX - Messico 24
BD - Bangladesh 22
PL - Polonia 22
HK - Hong Kong 20
BE - Belgio 17
ES - Italia 16
TR - Turchia 16
KR - Corea 15
ZA - Sudafrica 15
AR - Argentina 13
NL - Olanda 13
UA - Ucraina 13
IQ - Iraq 12
AT - Austria 9
CZ - Repubblica Ceca 9
IR - Iran 8
CO - Colombia 7
EC - Ecuador 7
LT - Lituania 7
MA - Marocco 7
AU - Australia 6
BY - Bielorussia 6
CI - Costa d'Avorio 6
GR - Grecia 6
NZ - Nuova Zelanda 6
PK - Pakistan 6
SA - Arabia Saudita 6
DK - Danimarca 5
PT - Portogallo 5
BG - Bulgaria 4
CH - Svizzera 4
CL - Cile 4
GY - Guiana 4
KE - Kenya 4
LB - Libano 4
PY - Paraguay 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
EG - Egitto 3
HU - Ungheria 3
JM - Giamaica 3
KZ - Kazakistan 3
MY - Malesia 3
PH - Filippine 3
RO - Romania 3
VE - Venezuela 3
NP - Nepal 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BZ - Belize 1
CY - Cipro 1
DZ - Algeria 1
EU - Europa 1
GE - Georgia 1
HN - Honduras 1
HR - Croazia 1
HT - Haiti 1
IL - Israele 1
KG - Kirghizistan 1
KH - Cambogia 1
LU - Lussemburgo 1
LV - Lettonia 1
ML - Mali 1
MM - Myanmar 1
PA - Panama 1
PE - Perù 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
Totale 5.100
Città #
Chandler 383
Singapore 380
Ashburn 218
New York 118
Dublin 99
Beijing 90
Dallas 79
Rome 72
Los Angeles 57
Jakarta 50
San Mateo 49
Frankfurt am Main 46
Munich 40
Boston 38
Princeton 35
Helsinki 34
Hefei 33
Moscow 33
Marseille 32
São Paulo 32
The Dalles 31
North Bergen 30
Wilmington 30
Chicago 22
Fairfield 22
Tokyo 22
Cattolica 20
Milan 20
Ho Chi Minh City 19
Hong Kong 19
Nanjing 19
Hanoi 17
Houston 17
Redwood City 15
Bologna 14
Bremen 14
Castelnuovo di Val di Cecina 14
Dearborn 14
Falls Church 14
Atlanta 13
Boardman 13
Poplar 13
Stockholm 13
Warsaw 13
Brussels 12
Jacksonville 12
Norwalk 12
Edinburgh 11
Hyderabad 11
Johannesburg 11
London 11
Nuremberg 11
Orem 11
San Francisco 11
Seattle 11
Seoul 11
Chennai 10
Denver 10
Kent 10
Montreal 10
Bexley 9
Brooklyn 9
Hebei 9
Mexico City 9
Woodbridge 9
Rio de Janeiro 8
Shenyang 8
Amsterdam 7
Ann Arbor 7
Dhaka 7
Falkenstein 7
Manchester 7
Querétaro 7
Santa Clara 7
Toronto 7
Abidjan 6
Augusta 6
Brno 6
Buffalo 6
Minsk 6
Roubaix 6
Auckland 5
Baghdad 5
Belo Horizonte 5
Curitiba 5
Düsseldorf 5
Lancaster 5
Palermo 5
Phoenix 5
Wroclaw 5
Ankara 4
Athens 4
Berlin 4
Cambridge 4
Campinas 4
Casablanca 4
Guangzhou 4
Istanbul 4
Izmir 4
Kish 4
Totale 2.769
Nome #
Long-Lasting Rituximab-Induced Reduction of Specific—But Not Total—IgG4 in MuSK-Positive Myasthenia Gravis 151
Immune dyscrasia in adult growth hormone deficiency: Evaluation of hemolytic complement activity (CH50) and IgG subclasses 148
Solving the mystery of HBV-related mixed cryoglobulinemia: potential biomarkers of disease progression 145
Salivary biomarkers in covid-19 patients: Towards a wide-scale test for monitoring disease activity 145
Biomarkers of minimal residual disease in rituximab-treated patients with mixed cryoglobulinemia 137
Immunological role of IgG subclasses 137
Evaluation of screening method for Bence Jones protein analysis 136
Serological Immunoglobulin-Free Light Chain Profile in Myasthenia Gravis Patients 135
Autoimmunity and lymphoproliferation markers in naïve HCV-RNA positive patients without clinical evidences of autoimmune/lymphoproliferative disorders 131
Biomarkers in HCV-related mixed cryoglobulinemia patients withnon-Hodgkin lymphoma 123
Serological profile of asymptomatic HCV positive patients with low level of cryoglobulins 118
The diagnostic performance of PIVKA-II in metabolic and viral hepatocellular carcinoma: A pilot study 118
Cytokines and Hepatocellular Carcinoma: Biomarkers of a Deadly Embrace 116
A novel biomarker score for the screening and management of patients with plasma cell proliferative disorders 116
Different biochemical patterns in type II and type III mixed cryoglobulinemia in HCV positive patients 115
Sentinel biomarkers in HCV positive patients with mixed cryoglobulinemia 115
Mono/polyclonal free light chains as challenging biomarkers for immunological abnormalities 115
The prognostic impact of monoclonal immune globulin and free light chain secretion in diffuse large B cell lymphoma (DLBCL) 114
NLRP3 Inflammasome Involvement in Heart, Liver, and Lung Diseases—A Lesson from Cytokine Storm Syndrome 113
Immunological role of IgG subclasses 113
Biomarkers in HCV-related mixed cryoglobulinemia patients withnon-Hodgkin lymphoma 109
Free light chains a novel biomarker of cardiovascular disease. A pilot study. 106
COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel 104
Laboratory investigation of hybrid igg4 k/λ in musk positive myasthenia gravis 104
FREE LIGHT CHAINS: A NEW POTENTIAL BIOMARKER FOR DISEASE STRATIFICATION IN NON-ALCOHOLIC STEATOHEPATITIS 103
Serological and Molecular Characterization of Hepatitis C Virus-Related Cryoglobulinemic Vasculitis in Patients without Cryoprecipitate 99
Cryoglobulins: Identification, classification, and novel biomarkers of mysterious proteins 99
Lack of association between Vitamin D status and free light chains profile with different chronic HCV-related liver and extrahepatic disorders 98
The Laboratory Role in anti-TNF Biological Therapy Era 95
Heavy chain disease: Our experience 93
IgG cryoglobulinemia 92
Circulating and Salivary NGF and BDNF Levels in SARS-CoV-2 Infection: Potential Predictor Biomarkers of COVID-19 Disease-Preliminary Data 90
Serum immunoglobulin free light chain levels in systemic autoimmune rheumatic diseases 90
Comparison of Fully Automated and Semiautomated Systems for Protein Immunofixation Electrophoresis 90
Serum and urine free light chains measurements in patients with systemic sclerosis: novel biomarkers for disease activity 89
Free light chains of immunoglobulins in patients with systemic sclerosis: correlations with lung involvement and inflammatory milieu 87
Cryoglobulins: putative effectors of adaptive immune response 86
Urinary lithogenic profile of patients with non-alcoholic fatty liver disease 83
Plasmatic free light chains as inflammatory marker in insulin resistance: comparison of metabolic syndrome with adult growth hormone deficiency 83
Serum free light chain quantitative assays: Dilemma of a biomarker 83
COVID-19, adaptative immune response and metabolic-associated liver disease 83
COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel 80
PREVALENCE OF ADVANCED LIVER FIBROSIS AMONG PRIMARY CARE PATIENTS WITH NAFLD. RESULTS FROM GENERAL PRACTITIONER DATABASE NAFLD (GPS-NAFLD) STUDY 76
Free light chains and autoimmunity 76
The dark side of current analytic methods for Bence Jones Proteinuria 75
Laboratory and Clinical Settings of Heavy/Light Chain (HLC) Assays in the Management of Monoclonal Gammopathies and Multiple Myeloma 74
General Practitioner databaSe NAFLD (GPS-NAFLD) Study: preva-lence of advanced liver fibrosis among Italian primary care pa-tients with NAFLD 73
Serum levels of free light chains and syndecan-1 in patients with rheumatoid arthritis and systemic lupus erythematosus 73
Circulating histone signature of human lean metabolic-associated fatty liver disease (MAFLD) 68
Multimorbidity and polypharmacotherapy in Italian primary care patients with NAFLD: General Practitioner databaSe NAFLD (GPS-NAFLD) Study 62
Cryoproteins in Non-HCV-Related Autoimmune Disorders: A Serious Cold-Induced Problem 39
Totale 5.203
Categoria #
all - tutte 24.144
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.144


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021119 0 0 0 0 0 4 2 4 10 6 52 41
2021/2022396 11 2 5 69 30 16 11 62 20 16 65 89
2022/20231.131 177 145 74 168 67 118 71 89 119 17 63 23
2023/2024581 31 144 8 54 15 107 46 24 8 25 52 67
2024/20251.144 53 37 83 46 102 52 21 60 172 110 217 191
2025/20261.561 360 57 203 393 532 16 0 0 0 0 0 0
Totale 5.203